Skip to content

Cholinomimetics

1. 
All the following are directly-acting cholinomimetic agents, except

2. 
All the following are pharmacological effects of directly-acting cholinomimetic agents, except

3. 
All the following are therapeutic indications of directly-acting cholinomimetic agents, except

4. 
All the following are adverse effects of directly-acting cholinomimetic agents, except

5. 
All the following are indirectly-acting cholinomimetic agents, except

6. 
All the following are pharmacological effects of indirectly-acting cholinomimetic agents, except

7. 
All the following are therapeutic indications of indirectly-acting cholinomimetic agents, except

8. 
All the following are adverse effects of indirectly-acting cholinomimetic agents, except

9. 
Duration of action of acetylcholine

10. 
Following is a direct-acting cholinomimetic agent

11. 
Side effect associated with systemic cholinomimetics is

12. 
Cholinomimetic used in the treatment of glaucoma is

13. 
Decrease in cardiac rate and force of contraction is mediated by stimulation of

14. 
Enzyme inhibited by indirect-acting cholinomimetics is

15. 
Drugs used to stimulate bladder function in patients with urinary retention is

16. 
NOT a direct-acting cholinomimetic agent

17. 
Cholinesterase inhibitor used in the management of Alzheimer's disease is

18. 
Activation of muscarinic receptors causes all the following except

19. 
Cholinomimetic used in the management of myasthenia gravis is

20. 
Following is a clinical use of neostigmine

Leave a Reply

Your email address will not be published. Required fields are marked *